FdaApplication

NDA 213978

Back to search

Identifiers

Properties

PropertyValue
applicant_nameOYSTER POINT PHARMA INC
application_typeNDA
approval_date2021-10-15

Products (1)

ProductActive ingredientStrengthDosage form
TYRVAYAVARENICLINE TARTRATEEQ 0.03MG BASE/SPRAYSPRAY;NASAL

1 product